Coexistence of bronchogenic carcinoma and active pulmonary tuberculosis

We describe 9 patients with coincident active tuberculosis of the lung and bronchogenic carcinoma who were all diagnosed within a 5-year period. All were men, with a mean age of 55 +/- 10 years. The principal symptom was toxic syndrome lasting 1-3 months and the most common X-ray sign was alveolar c...

Full description

Saved in:
Bibliographic Details
Published in:Archivos de bronconeumología 1995-01, Vol.31 (1), p.32
Main Authors: Martínez Moragón, E, Aparicio Urtasun, J, Cordero Rodríguez, P, Sanchís Aldás, J, León Fábregas, M, Perpiñá Tordera, M
Format: Article
Language:Spanish
Subjects:
Adenocarcinoma - complications
Adenocarcinoma, Bronchiolo-Alveolar - complications
Adult
Aged
Carcinoma, Bronchogenic - complications
Carcinoma, Bronchogenic - diagnostic imaging
Carcinoma, Large Cell - complications
Carcinoma, Squamous Cell - complications
Follow-Up Studies
Humans
Lung Neoplasms - complications
Lung Neoplasms - diagnostic imaging
Lung Neoplasms - mortality
Male
Middle Aged
Time Factors
Tomography, X-Ray Computed
Tuberculosis, Pulmonary - complications
Tuberculosis, Pulmonary - diagnostic imaging
Tuberculosis, Pulmonary - mortality
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:We describe 9 patients with coincident active tuberculosis of the lung and bronchogenic carcinoma who were all diagnosed within a 5-year period. All were men, with a mean age of 55 +/- 10 years. The principal symptom was toxic syndrome lasting 1-3 months and the most common X-ray sign was alveolar consolidation. Analysis of tissue samples revealed squamous carcinoma (4 cases), adenocarcinoma (4 cases, one of which was bronchioloalveolar) and non-small cell carcinoma (1 case). Tumoral stage was often advanced: IV (44%) and III (33%). The tuberculosis bacillus was isolated in sputum (100%) and in bronchial aspirate (50%); no in vitro resistance was observed. Three patients were treated with radical surgery and three with radiotherapy. Average survival was 3 months in this series.
ISSN:0300-2896